Navigation Links
CoreLab Partners Launches New DXA Imaging Service Offerings
Date:10/15/2010

PRINCETON, N.J., Oct. 15 /PRNewswire/ -- CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm Inc. and Medifacts International in February of this year, has launched a full suite of imaging service solutions and quality assurance processes as it relates to Dual Energy X-Ray Absorptiometry (DXA).

"We are pleased to announce that we have formally launched state-of-the-art imaging solutions to address the numerous indications and therapeutic areas of drug development requiring DXA imaging sciences," said CoreLab Partners' President and Chief Executive Officer, Dr. Mike Woehler. "The addition of DXA services to our growing list of modalities is a natural extension of our broad range of services as CoreLab Partners continues to expand its global reach and reputation for excellence across its cross-section of core lab services under our newly combined entity," added Woehler.  

This important launch correlates with the opening of the American Society of Bone Mineral Research (ASBMR) conference which will take place from October 15-19, 2010 at the Metro Toronto Convention Centre in Toronto, ON. Please visit CoreLab Partners at booth number #1507 to learn more about this exciting addition to their global suite of imaging sciences solutions and cardiac safety services.About CoreLab Partners, IncCoreLab Partners, with offices in North America, Europe and Asia, provides complete medical image assessment services to the pharmaceutical, biotechnology and medical device industries. An efficient operational process facilitates successful new drug development programs by employing an experienced clinical operations team combined with full-time, board certified, sub-specialty trained radiologists, cardiologists, nuclear medicine physicians and oncologists. CoreLab Partners also provides solutions for the collection, analysis and management of cardiac safety and efficacy information during drug development. Driven by best-in-class science, technology, and service quality, CoreLabs is a global leader providing ECG, TQT, Holter, Ambulatory Blood Pressure Monitoring, Spirometry, Glucometry, and Pulse Wave Analysis. Contact: Kevin D. DuffyVice President, Global Business DevelopmentEmail: kduffy@corelabpartners.comPhone: 609-936-2600This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE CoreLab Partners, Inc
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CoreLab Partners Completes First TQT Study in Japan
2. STALLERGENES : Significant Growth : Q3 2010 + 10% and +12% Over the First 9 Months / Shionogi Partnership: First EUR24 Million Instalment
3. UBC, Max Planck formalize partnership among worlds top quantum physicists
4. ReGear Life Sciences Partners with Life Care Centers of America
5. Signal Genetics Announces Partnership with Array BioPharma to Advance a Multiple Myeloma Program Backed by Companion Diagnostics
6. Oxford Resource Partners, LP and Mendel Biotechnology, Inc. Announce a Miscanthus Biomass Pilot Project in Ohio
7. Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation
8. Pennsylvania Partnerships Address Statewide Nursing Shortage
9. DSM Biomedical Announces Continued Partnership with Spinelab
10. NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership
11. Roche Diabetes Care and ICW Announce Technology Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software ... State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , ... Tremblay, President and COO of STACS DNA. “In further expanding our capacity as a ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:5/24/2016)... -- Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the ... latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Display- Ampronix News ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):